MMP14 and influenza: A selective MT1–MMP monoclonal antibody was demonstrated to be effective when used in combination with oseltamivir phosphate (Tamiflu) in an influenza virus model composed of PR8 influenza and Streptococcus pneumonia intra-nasal infection at sublethal doses [126].